Vertex Pharmaceuticals, Inc. (VRTX)
504.73
-2.01
(-0.40%)
USD |
NASDAQ |
Oct 02, 16:00
505.10
+0.37
(+0.07%)
After-Hours: 20:00
Vertex Pharmaceuticals Price to Book Value : 6.315 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 6.315 |
| October 01, 2026 | 6.340 |
| September 30, 2026 | 6.542 |
| September 29, 2026 | 6.591 |
| September 28, 2026 | 6.602 |
| September 25, 2026 | 6.584 |
| September 24, 2026 | 6.536 |
| September 23, 2026 | 6.461 |
| September 22, 2026 | 6.444 |
| September 21, 2026 | 6.390 |
| September 18, 2026 | 6.360 |
| September 17, 2026 | 6.461 |
| September 16, 2026 | 6.422 |
| September 15, 2026 | 6.439 |
| September 14, 2026 | 6.500 |
| September 11, 2026 | 6.449 |
| September 10, 2026 | 6.438 |
| September 09, 2026 | 6.520 |
| September 08, 2026 | 6.618 |
| September 04, 2026 | 6.833 |
| September 03, 2026 | 6.981 |
| September 02, 2026 | 6.966 |
| September 01, 2026 | 6.852 |
| August 31, 2026 | 6.813 |
| August 28, 2026 | 6.778 |
| Date | Value |
|---|---|
| August 27, 2026 | 6.851 |
| August 26, 2026 | 6.848 |
| August 25, 2026 | 6.917 |
| August 24, 2026 | 6.852 |
| August 21, 2026 | 6.857 |
| August 20, 2026 | 6.760 |
| August 19, 2026 | 6.908 |
| August 18, 2026 | 6.609 |
| August 17, 2026 | 6.451 |
| August 14, 2026 | 6.328 |
| August 13, 2026 | 6.462 |
| August 12, 2026 | 6.578 |
| August 11, 2026 | 6.627 |
| August 10, 2026 | 6.555 |
| August 07, 2026 | 6.207 |
| August 06, 2026 | 6.056 |
| August 05, 2026 | 6.066 |
| August 04, 2026 | 5.990 |
| August 03, 2026 | 5.890 |
| July 31, 2026 | 5.970 |
| July 30, 2026 | 6.027 |
| July 29, 2026 | 6.048 |
| July 28, 2026 | 6.136 |
| July 27, 2026 | 5.993 |
| July 24, 2026 | 5.973 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Alnylam Pharmaceuticals, Inc. | 21.70 |
| Gilead Sciences, Inc. | 15.18 |
| Sionna Therapeutics, Inc. | 0.8344 |
| Regeneron Pharmaceuticals, Inc. | 2.397 |
| Ionis Pharmaceuticals, Inc. | 16.40 |
Price to Book Value Related Metrics
| PE Ratio | 29.36 |
| PS Ratio | 10.19 |
| PEG Ratio | 1.285 |
| Price to Free Cash Flow | 34.08 |
| Price | 504.73 |
| Earnings Yield | 3.41% |
| Market Cap | 127.87B |
| PEGY Ratio | 1.285 |
| Operating PE Ratio | 25.76 |
| Normalized PE Ratio | 28.58 |